日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

在接受tisagenlecleucel治疗前进行改良的淋巴清除能否改善高危大B细胞淋巴瘤患者的预后?

Canelo-Vilaseca, Marta; Sabbah, Mohamad; Cristinelli, Caterina; Bommier, Côme; Sesques, Pierre; Roussel, Mikael; Bories, Pierre; Allain, Vincent; Ouedrani, Amani; De Bernardis, Ilenia; Vely, Agathe; Stephan, Pierre; Vercellino, Laetitia; Venet, Fabienne; Pescarmona, Rémi; Houot, Roch; Vergez, François; de Jorna, Romain; Madelaine, Isabelle; Parquet, Nathalie; Brignier, Anne C; Larghero, Jérôme; Mebarki, Miryam; Di Blasi, Roberta; Caillat-Zucman, Sophie; Thieblemont, Catherine

Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

更正:在接受 tisagenlecleucel 治疗前进行改良的淋巴清除能否改善高危大 B 细胞淋巴瘤患者的预后?

Canelo-Vilaseca, Marta; Sabbah, Mohamad; Cristinelli, Caterina; Bommier, Côme; Sesques, Pierre; Roussel, Mikael; Bories, Pierre; Allain, Vincent; Ouedrani, Amani; De Bernardis, Ilenia; Vely, Agathe; Stephan, Pierre; Vercellino, Laetitia; Venet, Fabienne; Pescarmona, Rémi; Houot, Roch; Vergez, François; de Jorna, Romain; Madelaine, Isabelle; Parquet, Nathalie; Brignier, Anne C; Larghero, Jérôme; Mebarki, Miryam; Di Blasi, Roberta; Caillat-Zucman, Sophie; Thieblemont, Catherine

High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial

对于初始治疗后进展/复发的局限期霍奇金淋巴瘤患者,大剂量化疗联合自体干细胞移植已成为首选的挽救治疗方案:EORTC/LYSA/FIL H10 试验的亚组分析

Manuel, Gotti; Stepanishyna, Yana; Skrypets, Tetiana; Marcheselli, Luigi; Cristinelli, Caterina; Botto, Barbara; Tonino, Sanne; Cavalieri, Doriane; Pulsoni, Alessandro; Hutchings, Martin; Hammoud, Mohammad; Fortpied, Catherine; Rigacci, Luigi; Plattel, Wouter; André, Marc; Federico, Massimo

Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study

左乙拉西坦常规预防在CD19 CAR-T治疗LBCL中并无益处:一项多中心倾向性匹配研究

Galli, Eugenio; Di Blasi, Roberta; Di Rocco, Alice; Cristinelli, Caterina; Pansini, Ilaria; Bommier, Côme; Corrente, Alessandro; De Bernardis, Ilenia; Viscovo, Marcello; Hohaus, Stefan; Modoni, Anna; Sorà, Federica; Chiusolo, Patrizia; Martelli, Maurizio; Sica, Simona; Thieblemont, Catherine

Lymphodepletion chemotherapy in chimeric antigen receptor-engineered T (CAR-T) cell therapy in lymphoma

淋巴瘤嵌合抗原受体工程化T细胞(CAR-T)疗法中的淋巴清除化疗

Canelo-Vilaseca, Marta; Sabbah, Mohamad; Di Blasi, Roberta; Cristinelli, Caterina; Sureda, Anna; Caillat-Zucman, Sophie; Thieblemont, Catherine

Baseline Cognitive and Neurological Status Does Not Modify the Occurrence of ICANS in CAR T-Cell Therapy for Aggressive B-Cell Lymphoma

基线认知和神经系统状态不影响CAR-T细胞疗法治疗侵袭性B细胞淋巴瘤中免疫相关神经系统疾病(ICANS)的发生率

Ursu, Renata; Barsan, Claudia; Di Blasi, Roberta; Belin, Catherine; Cuzzubbo, Stefania; El Soudany, Mohamed; Cristinelli, Caterina; Sivapragassame, Raghunath; Ouedrani, Amani; Thieblemont, Catherine; Caillat-Zucman, Sophie; Carpentier, Antoine F

Frail is not fail: Limited impact of comorbidities on non-relapse mortality and safety in patients with LBCL treated with CAR-T

虚弱并非失败:合并症对接受 CAR-T 疗法治疗的 LBCL 患者的非复发死亡率和安全性影响有限

Galli, Eugenio; Di Blasi, Roberta; Pansini, Ilaria; Cristinelli, Caterina; Bommier, Come; De Bernardis, Ilenia; Corrente, Alessandro; Viscovo, Marcello; Montini, Luca; Chiusolo, Patrizia; Hohaus, Stefan; Sorà, Federica; Thieblemont, Catherine; Sica, Simona

Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian Cohort

28例卡斯尔曼病患者的临床表现、治疗和预后:一项意大利队列的回顾性分析

Cristinelli, Caterina; Merli, Michele; Lucioni, Marco; Gotti, Manuel; Sciarra, Roberta; Rattotti, Sara; Carpi, Federico; Favrin, Gianmarco; Bianchi, Benedetta; Neri, Giuseppe; Coscia, Marta; Gambacorta, Marcello; Passamonti, Francesco; Paulli, Marco; Arcaini, Luca

Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma

局部霍奇金淋巴瘤反应适应性组间 EORTC/LYSA/FIL H10 试验的长期随访

Federico, Massimo; Fortpied, Catherine; Stepanishyna, Yana; Gotti, Manuel; van der Maazen, Richard; Cristinelli, Caterina; Re, Alessandro; Plattel, Wouter; Lazarovici, Julien; Merli, Francesco; Specht, Lena; Schiano de Colella, Jean-Marc; Hutchings, Martin; Versari, Annibale; Edeline, Véronique; Stamatoulas, Aspasia; Girinsky, Theodore; Ricardi, Umberto; Aleman, Berthe; Meulemans, Bart; Tonino, Sanne; Raemaekers, John; André, Marc

Interleukin-6 transcripts up-regulation in lymph nodes from unicentric and multicentric Castleman disease

单中心和多中心卡斯尔曼病患者淋巴结中白细胞介素-6转录本表达上调

Lucioni, Marco; Morello, Gaia; Cristinelli, Caterina; Fraticelli, Sara; Neri, Giuseppe; Travaglino, Erica; Minetto, Marco; Antoci, Francesca; Libretti, Paolo; Gambacorta, Marcello; Arcaini, Luca; Tripodo, Claudio; Paulli, Marco